600521 华海药业
已收盘 04-29 15:00:00
资讯
新帖
简况
华海药业最新公告:下属子公司获得注射用HB0052药物临床试验许可
证券之星 · 16分钟前
华海药业最新公告:下属子公司获得注射用HB0052药物临床试验许可
华海药业04月29日获主力加仓1217万元 环比增加1154.64%
自选股智能写手 · 15:17
华海药业04月29日获主力加仓1217万元 环比增加1154.64%
北向资金4月25日净买入华海药业5.75万股 连续3日增持
自选股智能写手 · 04-26
北向资金4月25日净买入华海药业5.75万股 连续3日增持
华海药业获融资买入0.15亿元,近三日累计买入0.34亿元
金融界 · 04-26
华海药业获融资买入0.15亿元,近三日累计买入0.34亿元
华海药业04月24日遭主力抛售2595万元 环比增加921.65%
自选股智能写手 · 04-24
华海药业04月24日遭主力抛售2595万元 环比增加921.65%
华海药业(600521.SH)获“白消安注射液”药品注册证书
智通财经 · 04-23
华海药业(600521.SH)获“白消安注射液”药品注册证书
华海药业最新公告:获得白消安注射液药品注册证书
证券之星 · 04-23
华海药业最新公告:获得白消安注射液药品注册证书
超级真菌概念盘中跳水,海正药业跌0.80%
自选股智能写手 · 04-18
超级真菌概念盘中跳水,海正药业跌0.80%
华海药业(600521.SH)获得托拉塞米片药品注册证书
智通财经网 · 04-16
华海药业(600521.SH)获得托拉塞米片药品注册证书
华海药业04月16日遭主力抛售3115万元 环比增加775.00%
自选股智能写手 · 04-16
华海药业04月16日遭主力抛售3115万元 环比增加775.00%
高血压概念盘中拉升,华海药业涨1.22%
自选股智能写手 · 04-16
高血压概念盘中拉升,华海药业涨1.22%
华海药业:预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元
证券之星 · 04-15
华海药业:预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元
华海药业(600521.SH):2023年度净利润8.26亿元 同比下降29.25%
智通财经网 · 04-15
华海药业(600521.SH):2023年度净利润8.26亿元 同比下降29.25%
华海药业(600521.SH):2023年净利润同比下降29.25%
格隆汇资讯 · 04-15
华海药业(600521.SH):2023年净利润同比下降29.25%
华海药业(600521.SH):恩格列净片获得药品注册证书
格隆汇资讯 · 04-15
华海药业(600521.SH):恩格列净片获得药品注册证书
华海药业(600521.SH):预计一季度净利润同比增加约50%到65%
格隆汇资讯 · 04-15
华海药业(600521.SH):预计一季度净利润同比增加约50%到65%
华海药业:2024年一季度业绩预增55%到70%
财通社 · 04-15
华海药业:2024年一季度业绩预增55%到70%
脑科学(脑机接口)概念盘中跳水,华海药业跌0.34%
自选股智能写手 · 04-15
脑科学(脑机接口)概念盘中跳水,华海药业跌0.34%
医药生物行业跟踪周报:原料药多维度积极变化,关注同和药业、华海药业等
东吴证券 · 04-15
医药生物行业跟踪周报:原料药多维度积极变化,关注同和药业、华海药业等
高血压概念盘中跳水,华海药业跌0.48%
自选股智能写手 · 04-12
高血压概念盘中跳水,华海药业跌0.48%
加载更多
公司概况
公司名称:
浙江华海药业股份有限公司
所属行业:
医药制造业
上市日期:
2003-03-04
主营业务:
浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月,公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”,同月,公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地;2023年6月,公司入选米内网颁发的2022年度中国化药企业百强等。
发行价格:
15.55
{"stockData":{"symbol":"600521","market":"SH","secType":"STK","nameCN":"华海药业","latestPrice":16.11,"timestamp":1714374000000,"preClose":16.05,"halted":0,"volume":16375403,"delay":0,"floatShares":1467000000,"shares":1483000000,"eps":0.6263,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"04-29 15:00:00","open":16.09,"high":16.35,"low":16,"amount":264000000,"amplitude":0.0218,"askPrice":16.11,"askSize":80,"bidPrice":16.1,"bidSize":234,"shortable":0,"etf":0,"ttmEps":0.6263,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714440600000},"adr":0,"adjPreClose":16.05,"symbolType":"stock","openAndCloseTimeList":[[1714354200000,1714361400000],[1714366800000,1714374000000]],"highLimit":17.66,"lowLimit":14.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1482507145,"pbRate":3.05,"roa":"--","roe":"9.14%","epsLYR":0.57,"committee":-0.09582,"marketValue":23883000000,"floatMarketCap":23629000000,"peRate":25.722498,"changeRate":0.0037,"turnoverRate":0.0112,"status":0},"requestUrl":"/m/hq/s/600521/","defaultTab":"news","newsList":[{"id":"2431805958","title":"华海药业最新公告:下属子公司获得注射用HB0052药物临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2431805958","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431805958?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:47","pubTimestamp":1714384051,"startTime":"0","endTime":"0","summary":"华海药业公告,下属子公司华奥泰及华博生物获得注射用HB0052药物临床试验许可。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900023105.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431006565","title":"华海药业04月29日获主力加仓1217万元 环比增加1154.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431006565","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431006565?lang=zh_cn&edition=full","pubTime":"2024-04-29 15:17","pubTimestamp":1714375059,"startTime":"0","endTime":"0","summary":"04月29日, 华海药业股价涨0.37%,报收16.11元,成交金额2.64亿元,换手率1.12%,振幅2.18%,量比1.09。华海药业今日主力资金净流入1217万元,上一交易日主力净流入97万元,今日环比增加1154.64%。|04月29日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|宜通世纪|5.75%|#|*ST嘉寓|4.27%|#|昊志机电|3.66%|#|宝利国际|3.26%|#|天晟新材|3.08%|#|日盈电子|2.87%|#|三六五网|2.78%|#|*ST名家|2.77%|#|德必集团|2.74%|#|中海达|2.71%|华海药业所在的化学制药行业,今日主力净流入5467万元,行业排名43/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042915213987bdf18c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042915213987bdf18c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430298426","title":"北向资金4月25日净买入华海药业5.75万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430298426","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430298426?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:30","pubTimestamp":1714095014,"startTime":"0","endTime":"0","summary":"4月25日, 北向资金增持华海药业5.75万股,连续3日增持。截止当日收盘,沪股通共持有华海药业3451.68万股,占流通股2.35%。沪股通增持金额前五个股分别为招商银行、中国平安、紫金矿业、中控技术、中信证券。华海药业近5个交易日上涨5.32%,沪股通累计减持117.80万股;近20个交易日上涨21.85%,沪股通累计增持6.83万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260931228b54f181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260931228b54f181&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430264054","title":"华海药业获融资买入0.15亿元,近三日累计买入0.34亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430264054","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430264054?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:14","pubTimestamp":1714090485,"startTime":"0","endTime":"0","summary":"4月25日,沪深两融数据显示,华海药业获融资买入额0.15亿元,居两市第404位,当日融资偿还额0.26亿元,净卖出1048.16万元。最近三个交易日,23日-25日,华海药业分别获融资买入0.11亿元、0.07亿元、0.15亿元。融券方面,当日融券卖出8.47万股,净卖出5.34万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042608162687b10399&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042608162687b10399&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429048850","title":"华海药业04月24日遭主力抛售2595万元 环比增加921.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429048850","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429048850?lang=zh_cn&edition=full","pubTime":"2024-04-24 15:17","pubTimestamp":1713943067,"startTime":"0","endTime":"0","summary":"04月24日,华海药业股价收平报15.69元,成交金额1.57亿元,换手率0.69%,振幅1.53%,量比0.56。华海药业今日主力资金净流出2595万元,连续5日净流出,上一交易日主力净流出254万元,今日环比增加921.65%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为57.14%,平均跌幅为1.71%。该股近5个交易日上涨3.50%,主力资金累计净流出3976万元;近20日主力资金累计净流出7453万元,其中净流出天数为14日。净流出前三个股分别为新和成、华海药业、贝达药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042415203787a99c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042415203787a99c85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429164513","title":"华海药业(600521.SH)获“白消安注射液”药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429164513","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429164513?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:12","pubTimestamp":1713867145,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)公告,公司于近日收到国家药品监督管理局(“国家药监局”)核准签发的白消安注射液的《药品注册证书》。据悉,白消安注射液适用于联合环磷酰胺,作为慢性髓性白血病同种异体的造血祖细胞移植前的预处理方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107660.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429161029","title":"华海药业最新公告:获得白消安注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429161029","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429161029?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:00","pubTimestamp":1713866410,"startTime":"0","endTime":"0","summary":"华海药业公告,获得白消安注射液药品注册证书。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300035354.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428458356","title":"超级真菌概念盘中跳水,海正药业跌0.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428458356","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428458356?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:38","pubTimestamp":1713404295,"startTime":"0","endTime":"0","summary":"04月18日,超级真菌概念盘中跳水,截至09点38分,超级真菌概念整体指数下跌0.69%,报727.100点。从个股上来看,该概念的成分股中,海正药业跌0.80%,哈药股份、联环药业、华海药业跌幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-2575.48万,其中华海药业受到资金热捧,主力净流入193.90万;拉长时间线来看,该板块近20日主力资金净流入-14.14亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809381587e817aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809381587e817aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427812222","title":"华海药业(600521.SH)获得托拉塞米片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2427812222","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2427812222?lang=zh_cn&edition=full","pubTime":"2024-04-16 16:16","pubTimestamp":1713255360,"startTime":"0","endTime":"0","summary":"华海药业发布公告,公司于近日收到国家药品监督管理局核准签发的托拉塞米片的《药品注册证书》。托拉塞米片获得国家药监局的《药品注册证书》,进一步丰富了公司的产品线,有助于提升公司产品的市场竞争力。根据国家相关政策,公司托拉塞米片按化学药品4类批准生产可视同通过一致性评价,医疗机构将会优先采购并在临床中优先选用,对公司的经营业绩产生积极的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-16/doc-inarziqs2542441.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-16/doc-inarziqs2542441.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427881666","title":"华海药业04月16日遭主力抛售3115万元 环比增加775.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427881666","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427881666?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:17","pubTimestamp":1713251858,"startTime":"0","endTime":"0","summary":"04月16日, 华海药业股价跌0.27%,报收14.76元,成交金额4.47亿元,换手率2.03%,振幅4.46%,量比1.01。华海药业今日主力资金净流出3115万元,连续3日净流出,上一交易日主力净流出356万元,今日环比增加775.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为66.67%,平均跌幅为1.57%。该股近5个交易日上涨11.90%,主力资金累计净流出4469万元;近20日主力资金累计净流出6781万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161522038b295e53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161522038b295e53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427862746","title":"高血压概念盘中拉升,华海药业涨1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427862746","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427862746?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:54","pubTimestamp":1713236041,"startTime":"0","endTime":"0","summary":"04月16日,高血压概念盘中拉升,截至10点53分,高血压概念整体指数上涨0.53%,报909.250点。从个股上来看,该概念的成分股中,华海药业涨1.22%,普洛药业、鱼跃医疗涨幅居前。从资金上来看,截止发稿,高血压概念主力净流入为-5752.98万,其中方盛制药受到资金热捧,主力净流入375.79万;拉长时间线来看,该板块近20日主力资金净流入-3.74亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161054017a5305bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161054017a5305bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427078765","title":"华海药业:预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427078765","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2427078765?lang=zh_cn&edition=full","pubTime":"2024-04-15 18:00","pubTimestamp":1713175233,"startTime":"0","endTime":"0","summary":"证券之星消息,华海药业发布业绩预告,预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元。华海药业2023年三季报显示,公司主营收入62.08亿元,同比上升6.33%;归母净利润7.22亿元,同比下降9.18%;扣非净利润7.69亿元,同比下降8.29%;其中2023年第三季度,公司单季度主营收入19.13亿元,同比下降5.02%;单季度归母净利润1.53亿元,同比下降32.57%;单季度扣非净利润1.47亿元,同比下降42.34%;负债率55.21%,投资收益-5480.12万元,财务费用6749.99万元,毛利率58.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415180136877f012d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415180136877f012d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427229010","title":"华海药业(600521.SH):2023年度净利润8.26亿元 同比下降29.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427229010","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2427229010?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:30","pubTimestamp":1713173431,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)披露2023年度业绩快报,该公司报告期实现营业总收入83.09亿元,同比增长0.52%。归属于上市公司股东的净利润8.26亿元,同比下降29.25%。归属于上市公司股东的扣除非经常性损益的净利润8.98亿元,同比下降22.08%。基本每股收益为0.57元/股。报告期内,该公司业绩下滑,主要是:原料药业务方面:受全球经济增速放缓、各国本土化政策推进等因素影响,原料药行业竞争加剧,部分产品价格下降影响公司利润减少。制剂业务方面:随着国内集采政策的持续深化,集采产品价格进一步下降影响公司利润进一步缩减。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415174110877eed64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415174110877eed64&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024418","title":"华海药业(600521.SH):2023年净利润同比下降29.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024418","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427024418?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:21","pubTimestamp":1713172908,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨华海药业(600521.SH)公布2023年度业绩快报,经初步核算,公司2023年度实现营业收入830,871.98万元,同比增长0.52%,实现归属于上市公司股东的净利润82,621.68万元,同比下降29.25%,其中归属于上市公司股东的扣除非经常性损益的净利润89,846.90万元,同比下降22.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415172159877edc85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415172159877edc85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427244900","title":"华海药业(600521.SH):恩格列净片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2427244900","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427244900?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:20","pubTimestamp":1713172853,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨华海药业(600521.SH)公布,近日收到国家药品监督管理局核准签发的恩格列净片的《药品注册证书》,恩格列净片用于治疗2型糖尿病和心力衰竭成人患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151721028b256a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151721028b256a18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024413","title":"华海药业(600521.SH):预计一季度净利润同比增加约50%到65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024413","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427024413?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:19","pubTimestamp":1713172781,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨华海药业公布,经财务部门初步测算,公司2024年一季度实现归属于上市公司股东的净利润预计在25,950万元至28,550万元之间,与上年同期相比,将增加约8,657万元到11,257万元,同比增加约50%到65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151719458b2568da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151719458b2568da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024416","title":"华海药业:2024年一季度业绩预增55%到70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024416","media":"财通社","top":-1,"share":"https://www.laohu8.com/m/news/2427024416?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:17","pubTimestamp":1713172620,"startTime":"0","endTime":"0","summary":"华海药业公告,公司2024年一季度归属于上市公司股东的扣除非经常性损益的净利润预计在29,220万元至32,050万元之间,与上年同期(法定披露数据)相比,将增加约10,365万元到13,195万元,同比增加约55%到70%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151718088b256706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151718088b256706&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427487950","title":"脑科学(脑机接口)概念盘中跳水,华海药业跌0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427487950","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427487950?lang=zh_cn&edition=full","pubTime":"2024-04-15 13:33","pubTimestamp":1713159229,"startTime":"0","endTime":"0","summary":"04月15日,脑科学(脑机接口)概念盘中跳水,截至13点33分,脑科学(脑机接口)概念整体指数下跌3.01%,报585.930点。从个股上来看,该概念的成分股中,华海药业跌0.34%,跌幅居前。从资金上来看,截止发稿,脑科学(脑机接口)概念主力净流入为-2.23亿,其中中科信息受到资金热捧,主力净流入3380.10万;拉长时间线来看,该板块近20日主力资金净流入-94.89亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151333497a52b947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151333497a52b947&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427056434","title":"医药生物行业跟踪周报:原料药多维度积极变化,关注同和药业、华海药业等","url":"https://stock-news.laohu8.com/highlight/detail?id=2427056434","media":"东吴证券","top":-1,"share":"https://www.laohu8.com/m/news/2427056434?lang=zh_cn&edition=full","pubTime":"2024-04-15 00:06","pubTimestamp":1713110765,"startTime":"0","endTime":"0","summary":"投资要点本周、年初至今医药指数涨幅分别为-3.03%、-14.25%,相对沪指的超额收益分别为-0.45%、-15.55%;本周中药、化药及医药商业等股价跌幅较小,医疗服务、医疗器械及生物制品等股价跌幅较大;本周涨幅居前诺唯赞、同和药业、万泰生物,跌幅居前英诺特、凯因科技、采纳股份。推荐同和药业、普洛药业、华海药业、天宇股份、美诺华等;关注健友股份、仙琚制药等。主要原因;其一医药政策积极转变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150006118b22130e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150006118b22130e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426924130","title":"高血压概念盘中跳水,华海药业跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426924130","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426924130?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:38","pubTimestamp":1712885931,"startTime":"0","endTime":"0","summary":"04月12日,高血压概念盘中跳水,截至09点38分,高血压概念整体指数下跌0.54%,报959.250点。从个股上来看,该概念的成分股中,华海药业跌0.48%,立方制药、方盛制药、昂利康跌幅居前。从资金上来看,截止发稿,高血压概念主力净流入为-1246.50万,其中润都股份受到资金热捧,主力净流入101.56万;拉长时间线来看,该板块近20日主力资金净流入3487.27万。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120938517a524663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120938517a524663&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2003-03-04","address":"浙江省台州市临海市汛桥","stockEarnings":[{"period":"1week","weight":0.0559},{"period":"1month","weight":0.2559},{"period":"3month","weight":0.2432},{"period":"6month","weight":0.0165},{"period":"1year","weight":-0.169},{"period":"ytd","weight":0.0941}],"companyName":"浙江华海药业股份有限公司","boardCode":"AI0027","perCapita":"20284股","boardName":"医药制造业","registeredCapital":"148250万元","compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0613},{"period":"6month","weight":0.0235},{"period":"1year","weight":-0.06},{"period":"ytd","weight":0.0382}],"survey":" 浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月,公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”,同月,公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地;2023年6月,公司入选米内网颁发的2022年度中国化药企业百强等。","serverTime":1714384967360,"listedPrice":15.55,"stockholders":"72310人(较上一季度减少1.88%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华海药业,600521,华海药业股票,华海药业股票老虎,华海药业股票老虎国际,华海药业行情,华海药业股票行情,华海药业股价,华海药业股市,华海药业股票价格,华海药业股票交易,华海药业股票购买,华海药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}